Page last updated: 2024-08-24

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Benign Neoplasms

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Benign Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
NIEMEYER, W1
HOLZER, H; SCHNEIDER, S; SCRIBA, P1
Hancock, CH; Hoffman, NW; Mondora, A; Tan, CT1
Griffin, JP; Krakoff, IH; McCormack, JJ; Newman, RA1
Bedikian, AY; Bodey, GP; Burgess, MA; Freireich, EJ1
Aisner, J; Budman, DA; Shulman, P; Sigman, LM; Van Echo, DA; Whitacre, MY1

Other Studies

6 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Benign Neoplasms

ArticleYear
[Critical observations on therapy of malignancy with the cytostatic Bayer A 139 in otorhinolaryngological therapeutics].
    Deutsches medizinisches Journal, 1958, Volume: 9, Issue:7

    Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Cyclohexenes; Ear Neoplasms; Nasal Cavity; Neoplasms; Paranasal Sinus Neoplasms; Pharynx

1958
[On the action of 2, 5-bis(2-methoxyethoxy)-3, 6-bis-ethylenimino-1, 4-benzoquinone (Bayer A 139) on the glycolysis of ascites tumor cells].
    Zeitschrift fur Krebsforschung, 1960, Volume: 63

    Topics: Animals; Antineoplastic Agents; Ascites; Aziridines; Benzoquinones; Carbohydrate Metabolism; Carbohydrates; Carcinoma, Ehrlich Tumor; Cyclohexenes; Glycolysis; Neoplasms

1960
Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
    Cancer research, 1984, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Central Nervous System Diseases; Child; Child, Preschool; Cyclohexenes; Drug Evaluation; Female; Hodgkin Disease; Humans; Infant; Leukemia; Male; Neoplasms

1984
Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
    Cancer treatment reports, 1982, Volume: 66, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Cyclohexenes; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia

1982
Phase I study of aziridinylbenzoquinone (NSC 182986).
    Cancer clinical trials, 1981,Winter, Volume: 4, Issue:4

    Topics: Adult; Aged; Anemia; Aziridines; Azirines; Benzoquinones; Bone Marrow; Cyclohexenes; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Stomatitis; Thrombocytopenia; Vomiting

1981
Phase I trial of 5-day continuous infusion aziridinylbenzoquinone (AZQ, diazaquone, NSC 182968).
    American journal of clinical oncology, 1986, Volume: 9, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Cyclohexenes; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Thrombocytopenia

1986